{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:04:51Z","timestamp":1770840291234,"version":"3.50.1"},"reference-count":98,"publisher":"Pacini Editore","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Otorhinolaryngol Ital"],"DOI":"10.14639\/0392-100x-2245","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T08:30:16Z","timestamp":1565166616000},"page":"5-18","source":"Crossref","is-referenced-by-count":10,"title":["Head and neck cutaneous basal cell carcinoma: what should the otorhinolaryngology head and neck surgeon care about?","Carcinoma basocellulare della cute del distretto testa e collo: cosa dovrebbe valutare il chirurgo otorinolaringoiatra e cervico-facciale?"],"prefix":"10.14639","volume":"40","author":[{"given":"Ant\u00f3nio","family":"Castanheira","sequence":"first","affiliation":[]},{"given":"Paula","family":"Boaventura","sequence":"additional","affiliation":[]},{"given":"Manuel Pais","family":"Clemente","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Soares","sequence":"additional","affiliation":[]},{"given":"Alberto","family":"Mota","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Manuel","family":"Lopes","sequence":"additional","affiliation":[]}],"member":"20340","published-online":{"date-parts":[[2020,2]]},"reference":[{"key":"10.14639\/0392-100X-2245_ref1","unstructured":"ACS (American Cancer Society). Cancer facts & figures 2017. Atlanta: American Cancer Society 2017. www.cancer.org"},{"key":"10.14639\/0392-100X-2245_ref2","doi-asserted-by":"crossref","unstructured":"Chinem VP, Miot HA. Epidemiology of basal cell carcinoma. An Bras Dermatol 2011;86:292-305. https:\/\/doi.org\/10.1590\/s0365-05962011000200013","DOI":"10.1590\/S0365-05962011000200013"},{"key":"10.14639\/0392-100X-2245_ref3","doi-asserted-by":"crossref","unstructured":"Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med 2005;353:2262-9. https:\/\/doi.org\/10.1056\/NEJMra044151","DOI":"10.1056\/NEJMra044151"},{"key":"10.14639\/0392-100X-2245_ref4","doi-asserted-by":"crossref","unstructured":"Holm AS, Nissen CV, Wulf HC. Basal cell carcinoma is as common as the sum of all other cancers: implications for treatment capacity. Acta Derm Venereol 2016;96:505-9. https:\/\/doi.org\/10.2340\/00015555-2282","DOI":"10.2340\/00015555-2282"},{"key":"10.14639\/0392-100X-2245_ref5","doi-asserted-by":"crossref","unstructured":"Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012;166:1069-80. https:\/\/doi.org\/10.1111\/j.1365-2133.2012.10830.x","DOI":"10.1111\/j.1365-2133.2012.10830.x"},{"key":"10.14639\/0392-100X-2245_ref6","unstructured":"WHO. World Health Statistics 2016: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2016. https:\/\/www.who.int\/gho\/publications\/world_health_statistics\/2016\/en\/"},{"key":"10.14639\/0392-100X-2245_ref7","unstructured":"Trakatelli M, Morton C, Nagore E, et al. Guidelines on the treatment of basal cell carcinoma. European Dermatology Forum 2012. http:\/\/www.euroderm.org\/edf\/index.php\/edf-guidelines\/category\/5-guidelines-miscellaneous"},{"key":"10.14639\/0392-100X-2245_ref8","doi-asserted-by":"crossref","unstructured":"Cameron M, Lee E, Hibler B, et al. Basal cell carcinoma: epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol 2019;80:303-17. https:\/\/doi.org\/10.1016\/j.jaad.2018.03.060","DOI":"10.1016\/j.jaad.2018.03.060"},{"key":"10.14639\/0392-100X-2245_ref9","doi-asserted-by":"crossref","unstructured":"Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol 2000;136:1524-30. https:\/\/doi.org\/10.1001\/archderm.136.12.1524","DOI":"10.1001\/archderm.136.12.1524"},{"key":"10.14639\/0392-100X-2245_ref10","doi-asserted-by":"crossref","unstructured":"Richmond-Sinclair NM, Pandeya N, Ware RS, et al. Incidence of basal cell carcinoma multiplicity and detailed anatomic distribution: longitudinal study of an Australian population. J Invest Dermatol 2009;129:323-8. https:\/\/doi.org\/10.1038\/jid.2008.234","DOI":"10.1038\/jid.2008.234"},{"key":"10.14639\/0392-100X-2245_ref11","doi-asserted-by":"crossref","unstructured":"de Vries E, Micallef R, Brewster DH, et al. Population-based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regions. Arch Dermatol 2012;148:347-54. https:\/\/doi.org\/10.1001\/archdermatol.2011.2244","DOI":"10.1001\/archdermatol.2011.2244"},{"key":"10.14639\/0392-100X-2245_ref12","doi-asserted-by":"crossref","unstructured":"Trakatelli M, Morton C, Nagore E, et al. Update of the European guidelines for basal cell carcinoma management. Eur J Dermatol 2014;24:312-29. https:\/\/doi.org\/10.1684\/ejd.2014.2271","DOI":"10.1684\/ejd.2014.2271"},{"key":"10.14639\/0392-100X-2245_ref13","doi-asserted-by":"crossref","unstructured":"Andrade P, Brites MM, Vieira R, et al. Epidemiology of basal cell carcinomas and squamous cell carcinomas in a Department of Dermatology: a 5 year review. An Bras Dermatol 2012;87:212-9. https:\/\/doi.org\/10.1590\/s0365-05962012000200004","DOI":"10.1590\/S0365-05962012000200004"},{"key":"10.14639\/0392-100X-2245_ref14","doi-asserted-by":"crossref","unstructured":"Hoban PR, Ramachandran S, Strange RC. Environment, phenotype and genetics: risk factors associated with BCC of the skin. Expert Rev Anticancer Ther 2002;2:570-9. https:\/\/doi.org\/10.1586\/14737140.2.5.570","DOI":"10.1586\/14737140.2.5.570"},{"key":"10.14639\/0392-100X-2245_ref15","doi-asserted-by":"crossref","unstructured":"Roewert-Huber J, Lange-Asschenfeldt B, Stockfleth E, et al. Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol 2007;157(Suppl 2):47-51. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08273.x","DOI":"10.1111\/j.1365-2133.2007.08273.x"},{"key":"10.14639\/0392-100X-2245_ref16","doi-asserted-by":"crossref","unstructured":"Christenson LJ, Borrowman TA, Vachon CM, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 2005;294:681-90. https:\/\/doi.org\/10.1001\/jama.294.6.681","DOI":"10.1001\/jama.294.6.681"},{"key":"10.14639\/0392-100X-2245_ref17","doi-asserted-by":"crossref","unstructured":"Mantese SAO, Berbert ALCV, Gomides MDA, et al. Carcinoma basocelular - An\u00e1lise de 300 casos observados em Uberl\u00e2ndia - MG. An Bras Dermatol 2006;81:136-42. http:\/\/www.scielo.br\/pdf\/%0D\/abd\/v81n2\/v81n02a04.pdf","DOI":"10.1590\/S0365-05962006000200004"},{"key":"10.14639\/0392-100X-2245_ref18","doi-asserted-by":"crossref","unstructured":"Souza CF, Thome EP, Menegotto PF, et al. Topography of basal cell carcinoma and their correlations with gender, age and histologic pattern: a retrospective study of 1042 lesions. An Bras Dermatol 2011;86:272-7. https:\/\/doi.org\/10.1590\/s0365-05962011000200010","DOI":"10.1590\/S0365-05962011000200010"},{"key":"10.14639\/0392-100X-2245_ref19","doi-asserted-by":"crossref","unstructured":"Maia M, Proenca NG, de Moraes JC. Risk factors for basal cell carcinoma: a case-control study. Rev Saude Publica 1995;29:27-37. https:\/\/doi.org\/10.1590\/s0034-89101995000100006","DOI":"10.1590\/S0034-89101995000100006"},{"key":"10.14639\/0392-100X-2245_ref20","doi-asserted-by":"crossref","unstructured":"Rocha FPd, Menezes AMB, Almeida Junior HLd, et al. Marcadores e fatores de risco para queratoses act\u00ednicas e carcinomas basocelulares: um estudo de caso-controle. An Bras Dermatol 2004;79:441-54. http:\/\/www.scielo.br\/pdf\/%0D\/abd\/v79n4\/v79n04a06.pdf","DOI":"10.1590\/S0365-05962004000400006"},{"key":"10.14639\/0392-100X-2245_ref21","doi-asserted-by":"crossref","unstructured":"Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B 2001;63:8-18. https:\/\/doi.org\/10.1016\/S1011-1344(01)00198-1","DOI":"10.1016\/S1011-1344(01)00198-1"},{"key":"10.14639\/0392-100X-2245_ref22","doi-asserted-by":"crossref","unstructured":"Diffey BL, Tate TJ, Davis A. Solar dosimetry of the face: the relationship of natural ultraviolet radiation exposure to basal cell carcinoma localisation. Phys Med Biol. 1979;24:931-9. https:\/\/iopscience.iop.org\/article\/10.1088\/0031-9155\/24\/5\/006\/pdf","DOI":"10.1088\/0031-9155\/24\/5\/006"},{"key":"10.14639\/0392-100X-2245_ref23","doi-asserted-by":"crossref","unstructured":"Green A, Williams G, Neale R, et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 1999;354:723-9. https:\/\/doi.org\/10.1016\/S0140-6736(98)12168-2","DOI":"10.1016\/S0140-6736(98)12168-2"},{"key":"10.14639\/0392-100X-2245_ref24","doi-asserted-by":"crossref","unstructured":"Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 1995;131:157-63. https:\/\/doi.org\/10.1001\/archderm.1995.01690140041006","DOI":"10.1001\/archderm.1995.01690140041006"},{"key":"10.14639\/0392-100X-2245_ref25","doi-asserted-by":"crossref","unstructured":"Chuang TY, Popescu A, Su WP, et al. Basal cell carcinoma. A population-based incidence study in Rochester, Minnesota. J Am Acad Dermatol 1990;22:413-7. https:\/\/doi.org\/10.1016\/0190-9622(90)70056-n","DOI":"10.1016\/0190-9622(90)70056-N"},{"key":"10.14639\/0392-100X-2245_ref26","doi-asserted-by":"crossref","unstructured":"Zhang M, Qureshi AA, Geller AC, et al. Use of tanning beds and incidence of skin cancer. J Clin Oncol 2012;30:1588-93. https:\/\/doi.org\/10.1200\/JCO.2011.39.3652","DOI":"10.1200\/JCO.2011.39.3652"},{"key":"10.14639\/0392-100X-2245_ref27","doi-asserted-by":"crossref","unstructured":"Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988;124:869-71. https:\/\/doi.org\/10.1001\/archderm.1988.01670060015008","DOI":"10.1001\/archderm.1988.01670060015008"},{"key":"10.14639\/0392-100X-2245_ref28","doi-asserted-by":"crossref","unstructured":"Zanetti R, Rosso S, Martinez C, et al. Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control study. Br J Cancer 2006;94:743-51. https:\/\/doi.org\/10.1038\/sj.bjc.6602982","DOI":"10.1038\/sj.bjc.6602982"},{"key":"10.14639\/0392-100X-2245_ref29","doi-asserted-by":"crossref","unstructured":"Kricker A, Armstrong BK, English DR, et al. Pigmentary and cutaneous risk factors for non-melanocytic skin cancer - a case-control study. Int J Cancer 1991;48:650-62. https:\/\/doi.org\/10.1002\/ijc.2910480504","DOI":"10.1002\/ijc.2910480504"},{"key":"10.14639\/0392-100X-2245_ref30","doi-asserted-by":"crossref","unstructured":"Gudbjartsson DF, Sulem P, Stacey SN, et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet 2008;40:886-91. https:\/\/doi.org\/10.1038\/ng.161","DOI":"10.1038\/ng.161"},{"key":"10.14639\/0392-100X-2245_ref31","doi-asserted-by":"crossref","unstructured":"Nan H, Kraft P, Hunter DJ, et al. Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians. Int J Cancer 2009;125:909-17. https:\/\/doi.org\/10.1002\/ijc.24327","DOI":"10.1002\/ijc.24327"},{"key":"10.14639\/0392-100X-2245_ref32","doi-asserted-by":"crossref","unstructured":"Stern RS, Study PUFA Follow-up Study. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study. J Am Acad Dermatol 2012;66:553-62. https:\/\/doi.org\/10.1016\/j.jaad.2011.04.004","DOI":"10.1016\/j.jaad.2011.04.004"},{"key":"10.14639\/0392-100X-2245_ref33","doi-asserted-by":"crossref","unstructured":"Lichter MD, Karagas MR, Mott LA, et al.; The New Hampshire Skin Cancer Study Group. Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. Arch Dermatol 2000;136:1007-11. https:\/\/doi.org\/10.1001\/archderm.136.8.1007","DOI":"10.1001\/archderm.136.8.1007"},{"key":"10.14639\/0392-100X-2245_ref34","doi-asserted-by":"crossref","unstructured":"Boaventura P, Oliveira R, Pereira D, et al. Head and neck basal cell carcinoma prevalence in individuals submitted to childhood X-ray epilation for tinea capitis treatment. Eur J Dermatol 2012;22:225-30. https:\/\/doi.org\/10.1684\/ejd.2012.1670","DOI":"10.1684\/ejd.2012.1670"},{"key":"10.14639\/0392-100X-2245_ref35","doi-asserted-by":"crossref","unstructured":"Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet 2010;375:673-85. https:\/\/doi.org\/10.1016\/S0140-6736(09)61196-X","DOI":"10.1016\/S0140-6736(09)61196-X"},{"key":"10.14639\/0392-100X-2245_ref36","doi-asserted-by":"crossref","unstructured":"Karagas MR, Tosteson TD, Blum J, et al. Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. Environ Health Perspect 1998;106(Suppl 4):1047-50. https:\/\/doi.org\/10.1289\/ehp.98106s41047","DOI":"10.1289\/ehp.98106s41047"},{"key":"10.14639\/0392-100X-2245_ref37","doi-asserted-by":"crossref","unstructured":"Karagas MR, Stukel TA, Umland V, et al. Reported use of photosensitizing medications and basal cell and squamous cell carcinoma of the skin: results of a population-based case-control study. J Invest Dermatol 2007;127:2901-3. https:\/\/doi.org\/10.1038\/sj.jid.5700934","DOI":"10.1038\/sj.jid.5700934"},{"key":"10.14639\/0392-100X-2245_ref38","doi-asserted-by":"crossref","unstructured":"Robinson SN, Zens MS, Perry AE, et al. Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study. J Invest Dermatol 2013;133:1950-5. https:\/\/doi.org\/10.1038\/jid.2013.33","DOI":"10.1038\/jid.2013.33"},{"key":"10.14639\/0392-100X-2245_ref39","unstructured":"Kossard S, Epstein EHJ, Cerio R, et al. Keratinocytic tumours - basal cell carcinoma. Lyon, France: World Health Organization 2006. https:\/\/www.iarc.fr\/en\/publications\/pdfs-online\/...\/bb6-cover.pdf"},{"key":"10.14639\/0392-100X-2245_ref40","unstructured":"Carucci JA, Pettersen DJLJS. Chapter 115. Basal cell carcinoma. In: Hill M (ed.). Fitzpatrick\u2019s Dermatology in General Medicine. New York, NY: McGraw-Hill; 2012. https:\/\/accessmedicine.mhmedical.com\/content.aspx?bookid=392&sectionid=41138832"},{"key":"10.14639\/0392-100X-2245_ref41","unstructured":"Kopke LF, Schmidt MS. Carcinoma basocelular. An Bras Dermatol 2002;77:249-82."},{"key":"10.14639\/0392-100X-2245_ref42","doi-asserted-by":"crossref","unstructured":"Kirkup ME, De Berker DA. Clinical measurement of dimensions of basal cell carcinoma: effect of waiting for elective surgery. Br J Dermatol 1999;141:876-9. https:\/\/doi.org\/10.1046\/j.1365-2133.1999.03111.x","DOI":"10.1046\/j.1365-2133.1999.03111.x"},{"key":"10.14639\/0392-100X-2245_ref43","doi-asserted-by":"crossref","unstructured":"Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual. Berlin: Springer; 2010. https:\/\/doi.org\/10.1245\/s10434-010-0985-4","DOI":"10.1245\/s10434-010-0985-4"},{"key":"10.14639\/0392-100X-2245_ref44","doi-asserted-by":"crossref","unstructured":"Correia de Sa TR, Silva R, Lopes JM. Basal cell carcinoma of the skin (part 2): diagnosis, prognosis and management. Future Oncol 2015;11:3023-38. https:\/\/doi.org\/10.2217\/fon.15.246","DOI":"10.2217\/fon.15.246"},{"key":"10.14639\/0392-100X-2245_ref45","unstructured":"Sobral Filho JF BG, Ramalho GL, et al. Variaveis epidemiologicas do carcinoma basocelular na Paraiba. CCS 1995;14:38-45."},{"key":"10.14639\/0392-100X-2245_ref46","doi-asserted-by":"crossref","unstructured":"Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol 2002;147:41-7. https:\/\/doi.org\/10.1046\/j.1365-2133.2002.04804.x","DOI":"10.1046\/j.1365-2133.2002.04804.x"},{"key":"10.14639\/0392-100X-2245_ref47","doi-asserted-by":"crossref","unstructured":"Bernard P, Dupuy A, Sasco A, et al. Basal cell carcinomas and actinic keratoses seen in dermatological practice in France: a cross-sectional survey. Dermatology 2008;216:194-9. https:\/\/doi.org\/10.1159\/000112925","DOI":"10.1159\/000112925"},{"key":"10.14639\/0392-100X-2245_ref48","unstructured":"Marzuka AG, Book SE. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med 2015;88:167-79. https:\/\/europepmc.org\/articles\/pmc4445438"},{"key":"10.14639\/0392-100X-2245_ref49","unstructured":"Dandurand M, Petit T, Martel P, et al. Management of basal cell carcinoma in adults Clinical practice guidelines. Eur J Dermatol 2006;16:394-401."},{"key":"10.14639\/0392-100X-2245_ref50","doi-asserted-by":"crossref","unstructured":"Pelucchi C, Di Landro A, Naldi L, et al.; Oncology Study Group of the Italian Group for Epidemiologic Research in D. Risk factors for histological types and anatomic sites of cutaneous basal-cell carcinoma: an italian case-control study. J Invest Dermatol 2007;127:935-44. https:\/\/doi.org\/10.1038\/sj.jid.5700598","DOI":"10.1038\/sj.jid.5700598"},{"key":"10.14639\/0392-100X-2245_ref51","doi-asserted-by":"crossref","unstructured":"Menzies SW, Westerhoff K, Rabinovitz H, et al. Surface microscopy of pigmented basal cell carcinoma. Arch Dermatol 2000;136:1012-6. https:\/\/doi.org\/10.1001\/archderm.136.8.1012","DOI":"10.1001\/archderm.136.8.1012"},{"key":"10.14639\/0392-100X-2245_ref52","doi-asserted-by":"crossref","unstructured":"Lallas A, Apalla Z, Argenziano G, et al. The dermatoscopic universe of basal cell carcinoma. Dermatol Pract Concept 2014;4:11-24. https:\/\/doi.org\/10.5826\/dpc.0403a02","DOI":"10.5826\/dpc.0403a02"},{"key":"10.14639\/0392-100X-2245_ref53","doi-asserted-by":"crossref","unstructured":"Betti R, Gualandri L, Cerri A, et al. Clinical features and histologic pattern analysis of pigmented basal cell carcinomas in an Italian population. J Dermatol 1998;25:691-4. https:\/\/doi.org\/10.1111\/j.1346-8138.1998.tb02484.x","DOI":"10.1111\/j.1346-8138.1998.tb02484.x"},{"key":"10.14639\/0392-100X-2245_ref54","doi-asserted-by":"crossref","unstructured":"Jain M, Madan NK, Agarwal S, et al. Pigmented basal cell carcinoma: cytological diagnosis and differential diagnoses. J Cytol 2012;29:273-5. http:\/\/www.jcytol.org\/text.asp?2012\/29\/4\/273\/103952","DOI":"10.4103\/0970-9371.103952"},{"key":"10.14639\/0392-100X-2245_ref55","doi-asserted-by":"crossref","unstructured":"Altamura D, Menzies SW, Argenziano G, et al. Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis. J Am Acad Dermatol 2010;62:67-75. https:\/\/doi.org\/10.1016\/j.jaad.2009.05.035","DOI":"10.1016\/j.jaad.2009.05.035"},{"key":"10.14639\/0392-100X-2245_ref56","doi-asserted-by":"crossref","unstructured":"Russell EB, Carrington PR, Smoller BR. Basal cell carcinoma: a comparison of shave biopsy versus punch biopsy techniques in subtype diagnosis. J Am Acad Dermatol 1999;41:69-71. https:\/\/doi.org\/10.1016\/s0190-9622(99)70409-3","DOI":"10.1016\/S0190-9622(99)70409-3"},{"key":"10.14639\/0392-100X-2245_ref57","doi-asserted-by":"crossref","unstructured":"Wolberink EA, Pasch MC, Zeiler M, et al. High discordance between punch biopsy and excision in establishing basal cell carcinoma subtype: analysis of 500 cases. J Eur Acad Dermatol Venereol 2013;27:985-9. https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04628.x","DOI":"10.1111\/j.1468-3083.2012.04628.x"},{"key":"10.14639\/0392-100X-2245_ref58","doi-asserted-by":"crossref","unstructured":"Telfer NR, Colver GB, Morton CA; British Association of D. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008;159:35-48. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08666.x","DOI":"10.1111\/j.1365-2133.2008.08666.x"},{"key":"10.14639\/0392-100X-2245_ref59","doi-asserted-by":"crossref","unstructured":"Bichakjian CK, Olencki T, Aasi SZ, et al. Basal cell skin cancer, version 1.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2016;14:574-97. https:\/\/doi.org\/10.6004\/jnccn.2016.0065","DOI":"10.6004\/jnccn.2016.0065"},{"key":"10.14639\/0392-100X-2245_ref60","doi-asserted-by":"crossref","unstructured":"Leibovitch I, Huilgol SC, Selva D, et al. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion. J Am Acad Dermatol 2005;53:458-63. https:\/\/doi.org\/10.1016\/j.jaad.2005.04.089","DOI":"10.1016\/j.jaad.2005.04.089"},{"key":"10.14639\/0392-100X-2245_ref61","doi-asserted-by":"crossref","unstructured":"Brown CI, Perry AE. Incidence of perineural invasion in histologically aggressive types of basal cell carcinoma. Am J Dermatopathol 2000;22:123-5.","DOI":"10.1097\/00000372-200004000-00006"},{"key":"10.14639\/0392-100X-2245_ref62","doi-asserted-by":"crossref","unstructured":"Bogelund FS, Philipsen PA, Gniadecki R. Factors affecting the recurrence rate of basal cell carcinoma. Acta Derm Venereol 2007;87:330-4. https:\/\/doi.org\/10.2340\/00015555-0236","DOI":"10.2340\/00015555-0236"},{"key":"10.14639\/0392-100X-2245_ref63","doi-asserted-by":"crossref","unstructured":"Von Hoff DD, LoRusso PM, Rudin CM, et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009;361:1164-72. https:\/\/doi.org\/10.1056\/NEJMoa0905360","DOI":"10.1056\/NEJMoa0905360"},{"key":"10.14639\/0392-100X-2245_ref64","doi-asserted-by":"crossref","unstructured":"Ganti AK, Kessinger A. Systemic therapy for disseminated basal cell carcinoma: an uncommon manifestation of a common cancer. Cancer Treat Rev 2011;37:440-3. https:\/\/doi.org\/10.1016\/j.ctrv.2010.12.002","DOI":"10.1016\/j.ctrv.2010.12.002"},{"key":"10.14639\/0392-100X-2245_ref65","doi-asserted-by":"crossref","unstructured":"McCusker M, Basset-Seguin N, Dummer R, et al. Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease. Eur J Cancer 2014;50:774-83. https:\/\/doi.org\/10.1016\/j.ejca.2013.12.013","DOI":"10.1016\/j.ejca.2013.12.013"},{"key":"10.14639\/0392-100X-2245_ref66","doi-asserted-by":"crossref","unstructured":"Walling HW, Fosko SW, Geraminejad PA, et al. Aggressive basal cell carcinoma: presentation, pathogenesis, and management. Cancer Metastasis Rev 2004;23:389-402. https:\/\/doi.org\/10.1023\/B:CANC.0000031775.04618.30","DOI":"10.1023\/B:CANC.0000031775.04618.30"},{"key":"10.14639\/0392-100X-2245_ref67","doi-asserted-by":"crossref","unstructured":"Batra RS, Kelley LC. A risk scale for predicting extensive subclinical spread of nonmelanoma skin cancer. Dermatol Surg 2002;28:107-12; discussion 112. https:\/\/doi.org\/10.1046\/j.1524-4725.2002.02902.x","DOI":"10.1046\/j.1524-4725.2002.02902.x"},{"key":"10.14639\/0392-100X-2245_ref68","doi-asserted-by":"crossref","unstructured":"Crowson AN. Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol 2006;19(Suppl 2):S127-47. https:\/\/doi.org\/10.1038\/modpathol.3800512","DOI":"10.1038\/modpathol.3800512"},{"key":"10.14639\/0392-100X-2245_ref69","doi-asserted-by":"crossref","unstructured":"Goldenberg G, Golitz LE, Fitzpatrick J. Histopathology of skin cancer. In: Stockfleth E, Rosen T, Schumaak S, editors. Managing skin cancer. Berlin Heidleberg: Springer-Verlag; 2010, Chapter 2. https:\/\/doi.org\/10.1007\/978-3-540-79347-2_2","DOI":"10.1007\/978-3-540-79347-2_2"},{"key":"10.14639\/0392-100X-2245_ref70","doi-asserted-by":"crossref","unstructured":"Fan H, Khavari PA. Sonic hedgehog opposes epithelial cell cycle arrest. J Cell Biol 1999;147:71-6. https:\/\/doi.org\/10.1083\/jcb.147.1.71","DOI":"10.1083\/jcb.147.1.71"},{"key":"10.14639\/0392-100X-2245_ref71","doi-asserted-by":"crossref","unstructured":"Kraft S, Granter SR. Molecular pathology of skin neoplasms of the head and neck. Arch Pathol Lab Med 2014;138:759-87. https:\/\/doi.org\/10.5858\/arpa.2013-0157-RA","DOI":"10.5858\/arpa.2013-0157-RA"},{"key":"10.14639\/0392-100X-2245_ref72","doi-asserted-by":"crossref","unstructured":"Greinert R. Skin cancer: new markers for better prevention. Pathobiology 2009;76:64-81. https:\/\/doi.org\/10.1159\/000201675","DOI":"10.1159\/000201675"},{"key":"10.14639\/0392-100X-2245_ref73","doi-asserted-by":"crossref","unstructured":"Witmanowski H, Szychta P, Blochowiak K, et al. Basal cell nevus syndrome (Gorlin-Goltz syndrome): genetic predisposition, clinical picture and treatment. Postepy Dermatol Alergol 2017;34:381-7. https:\/\/doi.org\/10.5114\/ada.2017.69323","DOI":"10.5114\/ada.2017.69323"},{"key":"10.14639\/0392-100X-2245_ref74","doi-asserted-by":"crossref","unstructured":"Pellegrini C, Maturo M, Di Nardo L, et al. Understanding the molecular genetics of basal cell carcinoma. Int J Mol Sci 2017;18:2485. https:\/\/doi.org\/10.3390\/ijms18112485","DOI":"10.3390\/ijms18112485"},{"key":"10.14639\/0392-100X-2245_ref75","doi-asserted-by":"crossref","unstructured":"Vinagre J, Pinto V, Celestino R, et al. Telomerase promoter mutations in cancer: an emerging molecular biomarker? Virchows Arch 2014;465:119-33. https:\/\/doi.org\/10.1007\/s00428-014-1608-4","DOI":"10.1007\/s00428-014-1608-4"},{"key":"10.14639\/0392-100X-2245_ref76","doi-asserted-by":"crossref","unstructured":"Populo H, Boaventura P, Vinagre J, et al. TERT promoter mutations in skin cancer: the effects of sun exposure and X-irradiation. J Invest Dermatol 2014;134:2251-7. https:\/\/doi.org\/10.1038\/jid.2014.163","DOI":"10.1038\/jid.2014.163"},{"key":"10.14639\/0392-100X-2245_ref77","doi-asserted-by":"crossref","unstructured":"Gaspar TB, Sa A, Lopes JM, et al. Telomere maintenance mechanisms in cancer. Genes (Basel) 2018;9:pii:E241. https:\/\/doi.org\/10.3390\/genes9050241","DOI":"10.3390\/genes9050241"},{"key":"10.14639\/0392-100X-2245_ref78","doi-asserted-by":"crossref","unstructured":"Correia de Sa TR, Silva R, Lopes JM. Basal cell carcinoma of the skin (part 1): epidemiology, pathology and genetic syndromes. Future Oncol 2015;11:3011-21. https:\/\/doi.org\/10.2217\/fon.15.246","DOI":"10.2217\/fon.15.246"},{"key":"10.14639\/0392-100X-2245_ref79","doi-asserted-by":"crossref","unstructured":"Silverman MK, Kopf AW, Bart RS, et al. Recurrence rates of treated basal cell carcinomas. Part 3: surgical excision. J Dermatol Surg Oncol 1992;18:471-6. https:\/\/doi.org\/10.1111\/j.1524-4725.1992.tb03307.x","DOI":"10.1111\/j.1524-4725.1992.tb03307.x"},{"key":"10.14639\/0392-100X-2245_ref80","doi-asserted-by":"crossref","unstructured":"Silverman MK, Kopf AW, Grin CM, et al. Recurrence rates of treated basal cell carcinomas. Part 2: curettage-electrodesiccation. J Dermatol Surg Oncol 1991;17:720-6. https:\/\/doi.org\/10.1111\/j.1524-4725.1991.tb03425.x","DOI":"10.1111\/j.1524-4725.1991.tb03425.x"},{"key":"10.14639\/0392-100X-2245_ref81","doi-asserted-by":"crossref","unstructured":"Nagore E, Grau C, Molinero J, et al. Positive margins in basal cell carcinoma: relationship to clinical features and recurrence risk. A retrospective study of 248 patients. J Eur Acad Dermatol Venereol 2003;17:167-70. https:\/\/doi.org\/10.1046\/j.1468-3083.2003.00535.x","DOI":"10.1046\/j.1468-3083.2003.00535.x"},{"key":"10.14639\/0392-100X-2245_ref82","doi-asserted-by":"crossref","unstructured":"Gulleth Y, Goldberg N, Silverman RP, et al. What is the best surgical margin for a Basal cell carcinoma: a meta-analysis of the literature. Plast Reconstr Surg 2010;126:1222-31. https:\/\/doi.org\/10.1097\/PRS.0b013e3181ea450d","DOI":"10.1097\/PRS.0b013e3181ea450d"},{"key":"10.14639\/0392-100X-2245_ref83","doi-asserted-by":"crossref","unstructured":"Rowe DE, Carroll RJ, Day CL Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989;15:424-31. https:\/\/doi.org\/10.1111\/j.1524-4725.1989.tb03249.x","DOI":"10.1111\/j.1524-4725.1989.tb03249.x"},{"key":"10.14639\/0392-100X-2245_ref84","doi-asserted-by":"crossref","unstructured":"Kimyai-Asadi A, Alam M, Goldberg LH, et al. Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas. J Am Acad Dermatol 2005;53:464-8. https:\/\/doi.org\/10.1016\/j.jaad.2005.03.038","DOI":"10.1016\/j.jaad.2005.03.038"},{"key":"10.14639\/0392-100X-2245_ref85","doi-asserted-by":"crossref","unstructured":"Luz FB, Ferron C, Cardoso GP. Analysis of effectiveness of a surgical treatment algorithm for basal cell carcinoma. An Bras Dermatol 2016;91:726-31. https:\/\/doi.org\/10.1590\/abd1806-4841.20165919","DOI":"10.1590\/abd1806-4841.20165919"},{"key":"10.14639\/0392-100X-2245_ref86","doi-asserted-by":"crossref","unstructured":"Luz FB, Ferron C, Cardoso GP. Surgical treatment of basal cell carcinoma: an algorithm based on the. An Bras Dermatol 2015;90:377-83. https:\/\/doi.org\/10.1590\/abd1806-4841.20153304","DOI":"10.1590\/abd1806-4841.20153304"},{"key":"10.14639\/0392-100X-2245_ref87","doi-asserted-by":"crossref","unstructured":"Lane JE, Kent DE. Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery. Curr Surg 2005;62:518-26. https:\/\/doi.org\/10.1016\/j.cursur.2005.01.003","DOI":"10.1016\/j.cursur.2005.01.003"},{"key":"10.14639\/0392-100X-2245_ref88","doi-asserted-by":"crossref","unstructured":"Leibovitch I, Huilgol SC, Selva D, et al. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. J Am Acad Dermatol 2005;53:452-7. https:\/\/doi.org\/10.1016\/j.jaad.2005.04.087","DOI":"10.1016\/j.jaad.2005.04.087"},{"key":"10.14639\/0392-100X-2245_ref89","unstructured":"Finley EM. The principles of mohs micrographic surgery for cutaneous neoplasia. Ochsner J 2003;5:22-33"},{"key":"10.14639\/0392-100X-2245_ref90","doi-asserted-by":"crossref","unstructured":"Batra RS, Kelley LC. Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery. Arch Dermatol 2002;138:1043-51. https:\/\/doi.org\/10.1001\/archderm.138.8.1043","DOI":"10.1001\/archderm.138.8.1043"},{"key":"10.14639\/0392-100X-2245_ref91","doi-asserted-by":"crossref","unstructured":"Zhang N, Yin Y, Xu SJ, et al. 5-Fluorouracil: mechanisms of resistance and reversal strategies. Molecules 2008;13:1551-69. https:\/\/doi.org\/10.3390\/molecules13081551","DOI":"10.3390\/molecules13081551"},{"key":"10.14639\/0392-100X-2245_ref92","doi-asserted-by":"crossref","unstructured":"Arits AH, Mosterd K, Essers BA, et al. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol 2013;14:647-54. https:\/\/doi.org\/10.1016\/S1470-2045(13)70143-8","DOI":"10.1016\/S1470-2045(13)70143-8"},{"key":"10.14639\/0392-100X-2245_ref93","doi-asserted-by":"crossref","unstructured":"Love WE, Bernhard JD, Bordeaux JS. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review. Arch Dermatol 2009;145:1431-8. https:\/\/doi.org\/10.1001\/archdermatol.2009.291","DOI":"10.1001\/archdermatol.2009.291"},{"key":"10.14639\/0392-100X-2245_ref94","doi-asserted-by":"crossref","unstructured":"Silverman MK, Kopf AW, Gladstein AH, et al. Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy. J Dermatol Surg Oncol 1992;18:549-54. https:\/\/doi.org\/10.1111\/j.1524-4725.1992.tb03508.x","DOI":"10.1111\/j.1524-4725.1992.tb03508.x"},{"key":"10.14639\/0392-100X-2245_ref95","unstructured":"Fellner C. Vismodegib (erivedge) for advanced basal cell carcinoma. P T 2012;37:670-82. www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3541861\/"},{"key":"10.14639\/0392-100X-2245_ref96","doi-asserted-by":"crossref","unstructured":"Sekulic A, Migden MR, Oro AE, et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 2012;366:2171-9. https:\/\/doi.org\/10.1056\/NEJMoa1113713","DOI":"10.1056\/NEJMoa1113713"},{"key":"10.14639\/0392-100X-2245_ref97","unstructured":"American College of Mohs Surgery. About Mohs Surgery. 2017.www.mohscollege.org\/about\/about-mohs-surgery (accessed December 2017)."},{"key":"10.14639\/0392-100X-2245_ref98","unstructured":"The Skin Cancer Foundation. Mohs surgery step by step. New York; 2017. https:\/\/www.skincancer.org\/skin-cancer-information\/mohs-surgery\/step-by-step"}],"container-title":["Acta Otorhinolaryngologica Italica"],"original-title":[],"link":[{"URL":"https:\/\/www.actaitalica.it\/article\/view\/419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T07:13:42Z","timestamp":1729667622000},"score":1,"resource":{"primary":{"URL":"https:\/\/old.actaitalica.it\/article\/view\/419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,2]]}},"URL":"https:\/\/doi.org\/10.14639\/0392-100x-2245","relation":{},"ISSN":["1827-675X"],"issn-type":[{"value":"1827-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]},"article-number":"2"}}